XCUR
ExicureยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
XCUR Profile
Exicure, Inc.
An early-stage biotechnology company that developing nucleic acid therapies targeting RNA to address neurological disorders and hair loss disorders
2430 N. Halsted St., Chicago, IL 60614
--
Exicure, Inc., was founded on July 9, 2015. The company is a clinical-stage biotechnology company that develops treatments for immuno-oncology, inflammatory diseases and genetic diseases based on its proprietary spherical nucleic acid (SNA) technology.
